drugset / Trial / NCT05407870

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

NCT05407870

Completed 138 enrolled Korea University Anam Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effects are frequently observed. However, etomidate is known to have hemodynamic and respiratory stability.The purpose of this study was to compare the efficacy and safety of etomidate and propofol in sedated gastric endoscopic submucosal dissection.

Timeline

Start
2022-06-09
Primary completion
2022-11-24
Completion
2022-11-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Etomidate Small molecule 0.05 mg/kg
Comparator Propofol Small molecule 0.25 mg/kg

Indications

No indication recorded.